Exact Mass: 590.345465
Exact Mass Matches: 590.345465
Found 382 metabolites which its exact mass value is equals to given mass value 590.345465
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Urobilinogen
C33H42N4O6 (590.3104192000001)
Urobilinogen is a tetrapyrrole chemical compound that is that is the parent compound of both stercobilin (the pigment that is responsible for the brown color of feces) and urobilin (the pigment that is responsible for the yellow color of urine). Urobilinogen is formed through the microbial degradation of its parent compound bilirubin. Urobilinogen is actually generated through the degradation of heme, the red pigment in haemoglobin and red blood cells (RBCs). RBCs have a life span of about 120 days. When the RBCs have reached the end of their useful lifespan, the cells are engulfed by macrophages and their constituents recycled or disposed of. Heme is broken down when the heme ring is opened by the enzyme known as heme oxygenase, which is found in the endoplasmic reticulum of the macrophages. The oxidation process produces the linear tetrapyrrole known as biliverdin along with ferric iron (Fe3+), and carbon monoxide (CO). In the next reaction, a second methylene group (located between rings III and IV of the porphyrin ring) is reduced by the enzyme known as biliverdin reductase, producing bilirubin. Bilirubin is significantly less extensively conjugated than biliverdin. This reduction causes a change in the color of the biliverdin molecule from blue-green (vert or verd for green) to yellow-red, which is the color of bilirubin (ruby or rubi for red). In plasma virtually all the bilirubin is tightly bound to plasma proteins, largely albumin, because it is only sparingly soluble in aqueous solutions at physiological pH. In the sinusoids unconjugated bilirubin dissociates from albumin, enters the liver cells across the cell membrane through non-ionic diffusion to the smooth endoplasmatic reticulum. In hepatocytes, bilirubin-UDP-glucuronyltransferase (bilirubin-UGT) adds 2 additional glucuronic acid molecules to bilirubin to produce the more water-soluble version of the molecule known as bilirubin diglucuronide. The bilirubin diglucuronide is transferred rapidly across the canalicular membrane into the bile canaliculi where it is then excreted as bile into the large intestine. The bilirubin is further degraded (reduced) by microbes present in the large intestine to form a colorless product known as urobilinogen. Urobilinogen that remains in the colon can either be reduced to stercobilinogen and finally oxidized to stercobilin, or it can be directly reduced to stercobilin. Some of the urobilinogen produced by the gut bacteria is reabsorbed and re-enters the enterohepatic circulation. This reabsorbed urobilinogen is oxidized and converted to urobilin. The urobilin is processed through the kidneys and then excreted in the urine, which causes the yellowish color in urine. Urobilinogen (also known as D-urobilinogen) is closely related to two other compounds: mesobilirubinogen (also known as I-urobilinogen) and stercobilinogen (also known as. L-urobilinogen). Specifically, urobilinogen can be reduced to form mesobilirubinogen, and mesobilirubinogen can be further reduced to form stercobilinogen. Confusingly, all three of these compounds are frequently collectively referred to as "urobilinogens". Urobilinogen content can be determined by a reaction with Ehrlichs reagent, which contains para-dimethylaminobenzaldehyde. Ehrlichs reagent reacts with urobilinogen to give a pink-red color. Low urine urobilinogen may result from complete obstructive jaundice or treatment with broad-spectrum antibiotics, which destroy the intestinal bacterial flora. Low urine urobilinogen levels may also result from congenital enzymatic jaundice (hyperbilirubinemia syndromes) or from treatment with drugs that acidify urine, such as ammonium chloride or ascorbic acid. Elevated urine levels of urinobilinogen may indicate hemolytic anaemia, a large hematoma, restricted liver function, hepatic infection, poisoning or liver cirrhosis. Urobilinogen is a colourless product of bilirubin reduction. It is formed in the intestines by bacterial action. Some urobilinogen is reabsorbed, taken up by the hepatocytes into the circulation and excreted by the kidney. This constitutes the normal "intrahepatic urobilinogen cycle".
Urobilin
C33H42N4O6 (590.3104192000001)
Urobilin, also known as urochrome, is the tetrapyrrole chemical compound that is primarily responsible for the yellow color of urine. Urobilin is formed through the oxidation of its parent compound uroblinogen. Urobilin is actually generated through the degradation of heme, the red pigment in haemoglobin and red blood cells (RBCs). RBCs have a life span of about 120 days. When the RBCs have reached the end of their useful lifespan, the cells are engulfed by macrophages and their constituents recycled or disposed of. Heme is broken down when the heme ring is opened by the enzyme known as heme oxygenase, which is found in the endoplasmic reticulum of the macrophages. The oxidation process produces the linear tetrapyrrole known as biliverdin along with ferric iron (Fe3+), and carbon monoxide (CO). In the next reaction, a second methylene group (located between rings III and IV of the porphyrin ring) is reduced by the enzyme known as biliverdin reductase, producing bilirubin. Bilirubin is significantly less extensively conjugated than biliverdin. This reduction causes a change in the color of the biliverdin molecule from blue-green (vert or verd for green) to yellow-red, which is the color of bilirubin (ruby or rubi for red). In plasma virtually all the bilirubin is tightly bound to plasma proteins, largely albumin, because it is only sparingly soluble in aqueous solutions at physiological pH. In the sinusoids unconjugated bilirubin dissociates from albumin, enters the liver cells across the cell membrane through non-ionic diffusion to the smooth endoplasmatic reticulum. In hepatocytes, bilirubin-UDP-glucuronyltransferase (bilirubin-UGT) adds 2 additional glucuronic acid molecules to bilirubin to produce the more water-soluble version of the molecule known as bilirubin diglucuronide. The bilirubin diglucuronide is transferred rapidly across the canalicular membrane into the bile canaliculi where it is then excreted as bile into the large intestine. The bilirubin is further degraded (reduced) by microbes present in the large intestine to form a colorless product known as urobilinogen. Some of the urobilinogen produced by the gut bacteria is reabsorbed and re-enters the enterohepatic circulation. These urobilinogens are oxidized and converted to urobilin. The urobilin is processed through the kidneys and then excreted in the urine, which causes the yellowish color in urine. Many urine tests monitor the amount of urobilin in urine, as this provides some useful insight into urinary tract function. Normally, urine would appear as either light yellow or colorless. A lack of water intake, for example following sleep or dehydration, reduces the water content of urine, thereby concentrating urobilin and producing a darker color of urine. Obstructive jaundice reduces biliary bilirubin excretion, which is then excreted directly from the blood stream into the urine, giving a dark-colored urine. This dark colored urine has a paradoxically low urobilin concentration.
(24R)-5b,8b-Epidioxyergosta-6,22E-dien-3b-ol 3-glucoside
(24R)-5b,8b-Epidioxyergosta-6,22E-dien-3b-ol 3-glucoside is found in mushrooms. (24R)-5b,8b-Epidioxyergosta-6,22E-dien-3b-ol 3-glucoside is a constituent of Lactarius volemus (tawny milkcap mushroom). Constituent of Lactarius volemus (tawny milkcap mushroom). (24R)-5b,8b-Epidioxyergosta-6,22E-dien-3b-ol 3-glucoside is found in mushrooms.
PA(14:1(9Z)/14:0)
PA(14:1(9Z)/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:1(9Z)/14:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
Benextramine
C32H54N4O2S2 (590.3687984000001)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
lasalocid
Cimilactone A
Cimilactone A is a natural product found in Actaea dahurica with data available.
Tanghinin
A cardenolide glycoside that is tanghinigenin attached to a 2-O-acetyl-6-deoxy-3-O-methyl-alpha-L-glucopyranosyl residue at position 3 via a glycosidc linkage. Isolated from Cerbera manghas, it exhibits cytotoxic activities against oral human epidermoid carcinoma (KB), human breast cancer cell (BC) and human small cells lung cancer. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
3,6,9,12,15,18,21,24,27,30,33,36-Dodecaoxaoctatriacontane-1,38-diol
2-[3-[(E)-6-acetyloxy-2-hydroxy-6-methyl-3-oxohept-4-en-2-yl]-6-(carboxymethyl)-2-hydroxy-3a,5a,9b-trimethyl-5-oxo-2,3,4,6,9,9a-hexahydro-1H-cyclopenta[a]naphthalen-7-yl]-2-methylpropanoic acid
caseamembrin Q|rel-(2S,5R,6S,7R,8S,9S,10R,18S,19R)-2,18-dibutanoyloxy-7,19-diacetoxy-18,19-epoxy-6,7-dihydroxy-cleroda-3,13(16),14-triene
5beta,6beta-epoxygorgostane-3beta,7alpha,11alpha,12beta,15alpha-pentol 11,15-diacetate
3alpha,7alpha-diacetoxy-17alpha-20S-21,24-epoxyapotirucall-14-ene-23R,24S,25-triol|chisopanin A
26-Sulfate-Stigmast-22-ene-3beta,5alpha,6beta,8beta,15alpha,24R,25R,26-heptol
1,3,4-Tri-Ac-(1beta,3beta,4beta,5beta,25S)-Spirostane-1,3,4,5-tetrol
25-O-acetyl-3-O-[beta-D-arabinopyranosyl]-(22E)-cholesta-5,22-diene-3beta,19,25-triol|junceelloside F
21H-Biline-8,12-dipropanoic acid, 3,18-diethyl-1,4,5,15,16,19,22,24-octahydro-2,7,13,17-tetramethyl-1,19-dioxo-
C33H42N4O6 (590.3104192000001)
5beta,6beta-epoxygorgostane-3beta,7alpha,11alpha,12beta,15alpha-pentol 12,15-diacetate
methyl-ent-15alpha-acetoxy-1alpha-(2-methyl-2,3-epoxybutyryloxy)-7alpha-isobutyryloxy-9alpha-hydroxykaur-16-en-19-oate|methyl-ent-15alpha-acetoxy-1alpha-<2-methyl-2,3-epoxybutyryloxy>-7alpha-isobutyryloxy-9alpha-hydroxykaur-16-en-19-oate
(22R,24xi)-5beta,6beta-epoxy-24-methyl-5alpha-cholestan-3beta,22,25,28-tetraol-3,22,28-triacetate
12alpha-acetoxy-16alpha-(3-hydroxypentanoyloxy)-20,24-dimethyl-24-oxoscalaran-25beta-oic acid
6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid
C34H54O8_(1alpha,3alpha,7alpha,9xi,13alpha,17xi,20xi)-3,21,23-Trihydroxy-4,4,8-trimethyl-24,25-epoxycholest-14-ene-1,7-diyl diacetate
C32H46O10_1H-Benz[e]indene-6,7-diacetic acid, 3-[(3E)-5-(acetyloxy)-1-hydroxy-1,5-dimethyl-2-oxo-3-hexen-1-yl]-2,3,3a,4,5,5a,6,9,9a,9b-decahydro-2-hydroxy-alpha~7~,alpha~7~,3a,5a,9b-pentamethyl-5-oxo
6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid [IIN-based on: CCMSLIB00000848016]
6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid [IIN-based on: CCMSLIB00000848017]
6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid [IIN-based: Match]
2-[3-[(E)-6-acetyloxy-2-hydroxy-6-methyl-3-oxohept-4-en-2-yl]-6-(carboxymethyl)-2-hydroxy-3a,5a,9b-trimethyl-5-oxo-2,3,4,6,9,9a-hexahydro-1H-cyclopenta[a]naphthalen-7-yl]-2-methylpropanoic acid_major
2-[3-[(E)-6-acetyloxy-2-hydroxy-6-methyl-3-oxohept-4-en-2-yl]-6-(carboxymethyl)-2-hydroxy-3a,5a,9b-trimethyl-5-oxo-2,3,4,6,9,9a-hexahydro-1H-cyclopenta[a]naphthalen-7-yl]-2-methylpropanoic acid_61.8\\%
Glu Met Arg Arg
C22H42N10O7S (590.2958502000001)
Glu Arg Met Arg
C22H42N10O7S (590.2958502000001)
Glu Arg Arg Met
C22H42N10O7S (590.2958502000001)
Phe Ile Arg Arg
Phe Leu Arg Arg
Phe Arg Ile Arg
Phe Arg Leu Arg
Phe Arg Arg Ile
Phe Arg Arg Leu
Ile Phe Arg Arg
Ile Arg Phe Arg
Ile Arg Arg Phe
Leu Phe Arg Arg
Leu Arg Phe Arg
Leu Arg Arg Phe
Met Glu Arg Arg
C22H42N10O7S (590.2958502000001)
Met Arg Glu Arg
C22H42N10O7S (590.2958502000001)
Met Arg Arg Glu
C22H42N10O7S (590.2958502000001)
Met Arg Val Trp
Met Arg Trp Val
Met Val Arg Trp
Met Val Trp Arg
Met Trp Arg Val
Met Trp Val Arg
Pro Arg Arg Tyr
C26H42N10O6 (590.3288632000001)
Pro Arg Tyr Arg
C26H42N10O6 (590.3288632000001)
Pro Tyr Arg Arg
C26H42N10O6 (590.3288632000001)
Arg Glu Met Arg
C22H42N10O7S (590.2958502000001)
Arg Glu Arg Met
C22H42N10O7S (590.2958502000001)
Arg Phe Ile Arg
Arg Phe Leu Arg
Arg Phe Arg Ile
Arg Phe Arg Leu
Arg Ile Phe Arg
Arg Ile Arg Phe
Arg Leu Phe Arg
Arg Leu Arg Phe
Arg Met Glu Arg
C22H42N10O7S (590.2958502000001)
Arg Met Arg Glu
C22H42N10O7S (590.2958502000001)
Arg Met Val Trp
Arg Met Trp Val
Arg Pro Arg Tyr
C26H42N10O6 (590.3288632000001)
Arg Pro Tyr Arg
C26H42N10O6 (590.3288632000001)
Arg Arg Glu Met
C22H42N10O7S (590.2958502000001)
Arg Arg Phe Ile
Arg Arg Phe Leu
Arg Arg Ile Phe
Arg Arg Leu Phe
Arg Arg Met Glu
C22H42N10O7S (590.2958502000001)
Arg Arg Pro Tyr
C26H42N10O6 (590.3288632000001)
Arg Arg Tyr Pro
C26H42N10O6 (590.3288632000001)
Arg Val Met Trp
Arg Val Trp Met
Arg Trp Met Val
Arg Trp Val Met
Arg Tyr Pro Arg
C26H42N10O6 (590.3288632000001)
Arg Tyr Arg Pro
C26H42N10O6 (590.3288632000001)
Val Met Arg Trp
Val Met Trp Arg
Val Arg Met Trp
Val Arg Trp Met
Val Trp Met Arg
Val Trp Arg Met
Trp Met Arg Val
Trp Met Val Arg
Trp Arg Met Val
Trp Arg Val Met
Trp Val Met Arg
Trp Val Arg Met
Tyr Pro Arg Arg
C26H42N10O6 (590.3288632000001)
Tyr Arg Pro Arg
C26H42N10O6 (590.3288632000001)
Tyr Arg Arg Pro
C26H42N10O6 (590.3288632000001)
Lasalocid
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents A polyether antibiotic used for prevention and treatment of coccidiosis in poultry. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic D049990 - Membrane Transport Modulators D007476 - Ionophores Lasalocid (Lasalocid-A; Ionophore X-537A; Antibiotic X-537A) is an antibacterial and anticoccidial agent used in feed additives.
(24R)-5b,8b-Epidioxyergosta-6,22E-dien-3b-ol 3-glucoside
(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol
butyl 2-methylprop-2-enoate,butyl prop-2-enoate,2-hydroxypropyl 2-methylprop-2-enoate,prop-2-enoic acid,styrene
2-((e)-3-(5,5-dimethyl-3-[(e)-3-(1,3,3-trimethyl-1,3-dihydro-2h-indol-2-ylidene)-1-propenyl]-2-cyclohexen-1-ylidene)-1-propenyl)-1,3,3-trimethyl-3h-indolium tetrafluoroborate
C36H43BF4N2 (590.3455236000001)
I-urobilin
C33H42N4O6 (590.3104192000001)
Urobilin is one of the final by-products of hemoglobin breakdown. Urobilin is excreted in both the urine and feces from many mammals, particularly humans. The breakdown of hemoglobin to biliverdin is common to most animals, while the next step, the conversion of biliverdin to bilirubin, and subsequently to the urobilinogens (urobilin is one particular oxidized chemical form of urobilinogen) is unique to mammals. (PMID: 16604237) [HMDB]
Egonol Oleate
A fatty acid ester obtained by the formal condensation of egonol with oleic acid. It has been isolated from the fruits of Styrax agrestis.
(2S,3S,4S,5E)-4-(2-carboxyethyl)-5-[2-[[5-[(3-ethenyl-4-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-3-ethyl-4-methyl-1H-pyrrol-2-yl]methyl]-3-methyl-4-oxo-3a,6a-dihydro-1H-cyclopenta[b]pyrrol-6-ylidene]-3-methylpyrrolidine-2-carboxylic acid
C33H42N4O6 (590.3104192000001)
1-cyclohexyl-3-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea
1-cyclohexyl-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea
1-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
[(1R,2R,6S,7S,8R,10S,11S,12R,14S,16S,17R,18R)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-14-nonyl-5-oxo-16-prop-1-en-2-yl-9,13,15,19-tetraoxahexacyclo[12.4.1.01,11.02,6.08,10.012,16]nonadec-3-en-17-yl] acetate
1-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea
C34H46N4O5 (590.3468025999999)
1-cyclohexyl-3-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea
[(1R,2R,3R,4S,5R,6S,7S,9R,10S,11S,13S,14R,15S,23S,25R)-10,11-dihydroxy-9-(hydroxymethyl)-2,13,15-trimethyl-12-oxo-4-prop-1-en-2-yl-8,24,26,27-tetraoxaheptacyclo[12.10.1.14,23.15,23.01,6.07,9.011,25]heptacosan-3-yl] acetate
[(1R,2R,3R,4S,5R,6S,7S,9R,10S,11S,13S,14R,15R,23S,25R)-10,11-dihydroxy-9-(hydroxymethyl)-2,13,15-trimethyl-12-oxo-4-prop-1-en-2-yl-8,24,26,27-tetraoxaheptacyclo[12.10.1.14,23.15,23.01,6.07,9.011,25]heptacosan-3-yl] acetate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-henicos-11-enoate
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-nonadec-9-enoate
(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (Z)-docos-13-enoate
(1-acetyloxy-3-phosphonooxypropan-2-yl) (Z)-hexacos-15-enoate
(1-octanoyloxy-3-phosphonooxypropan-2-yl) (Z)-icos-11-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetracos-13-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (Z)-pentadec-9-enoate
[3-phosphonooxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] tetradecanoate
(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-heptadec-9-enoate
(1-decanoyloxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate
(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexadec-9-enoate
[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] pentadecanoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-9-enoate
[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] tetradecanoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] octadec-17-enoate
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-pentadec-9-enoate
[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] tetradecanoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-octadec-11-enoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-heptadec-9-enoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-7-enoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-octadec-6-enoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-octadec-4-enoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] octadec-17-enoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-octadec-9-enoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-6-enoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-octadec-7-enoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-13-enoate
[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-hexadec-9-enoate
[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-hexadec-7-enoate
[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-hexadec-9-enoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-11-enoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-octadec-13-enoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-heptadec-9-enoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-4-enoate
[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-hexadec-7-enoate
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-pentadec-9-enoate
2-[[3-butanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-acetyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
3-[(2E)-2-[[3-(2-carboxyethyl)-5-[(3-ethyl-4-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-2-yl]methylene]-5-[(4-ethyl-3-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-4-methyl-pyrrol-3-yl]propanoic acid
C33H42N4O6 (590.3104192000001)
1,2-ditetradecanoyl-sn-glycerol-3-phosphate(2-)
A 1-acyl-2-tetradecanoyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of both phosphate OH groups of 1,2-ditetradecanoyl-sn-glycerol-3-phosphate(; major species at pH 7.3.
1-(9Z-tetradecenoyl)-2-tetradecanoyl-glycero-3-phosphate
1-dodecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphate
1,2-Dimyrsitoylphosphatidate(2-)
A phosphatidate(2-) obtained by deprotonation of both phosphate OH groups of 1,2-dimyristoylphosphatidic acid; major species at pH 7.3.
rel-1,2-Dihydro-5-hydroxy-9R-methyl-6alpha,7alpha-epoxy-12beta-acetoxy-9,13,14-ortho-1alpha-decenoate-resiniferonol-10-oic acid
A natural product found in Pimelea elongata.
rel-1,2-Dihydro-5-hydroxy-9S-methyl-6alpha,7alpha-epoxy-12beta-acetoxy-9,13,14-ortho-1alpha-decenoate-resiniferonol-10-oic acid
A natural product found in Pimelea elongata.
BMS-193885
C33H42N4O6 (590.3104192000001)
BMS-193885 is a potent, selective, competitive, and brain penetrant neuropeptide Y1 receptor antagonist with a Ki of 3.3 nM, and has an IC50 of 5.9 nM for hY1, which displays > 100, > 160, > 160 and > 160-fold selectivity over α1, hY2, hY4 and hY5 receptors, respectively [1] [2].
(2e)-n-[(2e,6z,8z)-11-{4-[(2s)-2-[(3s,4r)-4,8-dihydroxy-7-methyl-1-oxo-3,4-dihydro-2-benzopyran-3-yl]propyl]-1,3-oxazol-2-yl}dodeca-2,6,8,11-tetraen-1-yl]-3-methoxy-n-methylbut-2-enamide
9,12-dihydroxy-10-[(4-hydroxyphenyl)methyl]-6-methyl-3-(2-methylpropyl)-16-(4-phenylbut-3-en-2-yl)-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione
(2r,3s,4r,5s,6s)-5-hydroxy-2-{[(1r,3s,5s,7s,10s,11r,14r,15r,18r)-18-hydroxy-10,14-dimethyl-15-(5-oxo-2h-furan-3-yl)-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-7-yl]oxy}-4-methoxy-6-methyloxan-3-yl acetate
(1'r,2r,2'r,3'r,4's,5's,6'r,8'r,11'r)-2'-(acetyloxy)-5'-{2-[(3s)-2-hydroxyoxolan-3-yl]ethyl}-4',5'-dimethyl-11'-{[(2e)-2-methylbut-2-enoyl]oxy}-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-3'-yl (2e)-2-methylbut-2-enoate
(1r,2r,3r,5s,8r,9r,10r)-9,10-bis(acetyloxy)-8,12,15,15-tetramethyl-4-methylidene-13-oxo-5-[(triethylsilyl)oxy]tricyclo[9.3.1.0³,⁸]pentadec-11-en-2-yl acetate
(1r,3r,4r,5r,6r,10s,12s,13s,16r,18s,21r)-4,6,12,17,17-pentamethyl-8-oxo-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan-3-yl acetate
(1r,2s,5s,7r,9r,11r,12s,15r,16r,18r)-15-[(2s)-4-hydroxy-5,6-dimethyl-3-oxoheptan-2-yl]-2,16-dimethyl-10-oxo-8,19-dioxahexacyclo[9.8.0.0¹,¹⁸.0²,⁷.0⁷,⁹.0¹²,¹⁶]nonadecan-5-yl 2,3-dihydroxy-3-methylbutanoate
5'-bromo-6-{7-hydroxy-7-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4-methylheptyl}-2',5,6',6'-tetramethyl-[2,2'-bioxan]-5-ol
(1s,3s,4r,9r,12e,14s)-14-hydroxy-9-[(1r)-1-hydroxyethyl]-3-[(2s,5s)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadec-12-ene-7,11-dione
(2r,3r,4s,5s,6r)-2-{[(1s,2r,5r,6r,9r,10r,13s,15s)-5-[(2r,3e,5s)-5,6-dimethylhept-3-en-2-yl]-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadec-18-en-13-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r)-2-[(2r,3s)-2-(acetyloxy)-3-[(1s,2r,5s,7s,9r,11s,12s,15r,16s)-5-(acetyloxy)-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-15-yl]butyl]-3-hydroxy-3-methylbutyl acetate
5α,8α-epidioxy-24(r)-methylcholesta-6,22-dien-3β-d-glucopyranoside
{"Ingredient_id": "HBIN011391","Ingredient_name": "5\u03b1,8\u03b1-epidioxy-24(r)-methylcholesta-6,22-dien-3\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C34H54O8","Ingredient_Smile": "CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C24C=CC5(C3(CCC(C5)OC6C(C(C(C(O6)CO)O)O)O)C)OO4)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15256","TCMID_id": "6906","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}